RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury
Circulation · 2026
DOI: 10.1161/circulationaha.125.075591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Zhenyu Xiong und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sixth Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China (Z.X., Y.L., J. Liu, Y.C.). Hauptthemen laut MEDLINE: rho GTP-Binding Proteins, Myocardial Reperfusion Injury, Glucose, Pyruvate Dehydrogenase (Lipoamide). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Metabolic disturbances are key contributors to myocardial ischemia-reperfusion (I/R) injury, yet the underlying molecular mechanisms remain largely unclear. Rho family GTPase 3 (RND3), a cytosolic small guanosine triphosphatase (GTPase) known to antagonize ROCK1 (Rho-associated coiled-coil kinase 1), has been implicated in several cardiovascular disorders. However, its mitochondrial localization and functional role in cardiac energy metabolism and I/R injury remain unknown. METHODS: A murine model of myocardial I/R injury was established through left anterior descending coronary artery ligation. Mice with cardiomyocyte-specific knockout and overexpression of Rnd3 were generated. To investigate the role of RND3 in cardiac metabolism and I/R injury, we used 13 C-nuclear magnetic resonance, 18 F-fluorodeoxyglucose positron emission tomography/computed tomography scanning, seahorse mitochondrial energy metabolism assays, and 13 C-metabolic flux tracing. Mechanistic studies were conducted using RNA sequencing, coimmunoprecipitation, mass spectrometry, and glutathione S-transferase (GST) pulldown assays. RESULTS: Cardiomyocyte-specific deletion of Rnd3 ( Rnd3 conditional knockout, Rnd3 cKO ) resulted in impaired glucose oxidation and compensatory upregulation of fatty acid oxidation, leading to pronounced cardiac dysfunction and increased mortality. Rnd3 cKO hearts exhibited reduced pyruvate/malate-driven complex I respiration and marked uncoupling between glycolysis and the tricarboxylic acid cycle. Mechanistically, RND3 was identified as a novel mitochondrial matrix-localized small GTPase that directly binds to ACAT1 (acetyl-coenzyme A [CoA] acetyltransferase), disrupting its interaction with PDHA1 (pyruvate dehydrogenase E1α subunit) and thereby promoting PDHA1 acetylation and glucose oxidation. It is important to note that RND3 expression was significantly downregulated in both human and murine hearts after I/R insult. Loss of RND3 sensitized the hearts to I/R injury, as evidenced by reduced levels of phosphocreatine and ATP. Conversely, cardiac-specific overexpression of Rnd3 conferred protection against I/R injury, an effect that was abolished upon Pdha1 knockdown. CONCLUSIONS: Our results identify RND3 as a novel mitochondria-localized regulator of glucose oxidation that safeguards the heart against I/R injury. Therapeutic reconstitution of Rnd3 may represent a promising strategy to restore metabolic homeostasis and mitigate myocardial damage in the context of I/R.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sixth Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China (Z.X., Y.L., J. Liu, Y.C.).
- Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi' an, China (Y.Z., M.Q., H.Z., X.Z., M.J., C.L., J. Lin, D.S.).
- Department of Ultrasound Diagnosis, No. 941 Hospital of Joint Logistics Support Force, Xining, China (Z.M.).
- Center for Translational Medicine, Temple University, Philadelphia, PA (E.G.).
- Department of Cardiology, General Hospital of Western Theater Command of Chinese PLA, Chengdu, China (W.M.).
- Department of Cardiology, Tangdu Hospital, Air Force Medical University, Xi' an, China (M.Z., J.H.).
ORCID-Profile: Zhenyu Xiong, Yueyang Li, Yan Zhang, Zhengjun Ma, Meiying Qi, Huanle Zhang, Xiaohua Zhang, Mengyuan Jiang, Jie Liu, Congye Li, Wanrong Man, Mingming Zhang, Jianqiang Hu, Jie Lin, Zhi Yang, Li Fan, Yundai Chen, Dongdong Sun
Zitieren
APA
Xiong, Z., Li, Y., Zhang, Y., Ma, Z., Qi, M., Zhang, H., Zhang, X., Jiang, M., Liu, J., Gao, E., Li, C., Man, W., Zhang, M., Hu, J., Lin, J., Yang, Z., Fan, L., Chen, Y., & Sun, D. (2026). RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury. Circulation. https://doi.org/10.1161/circulationaha.125.075591
Vancouver
Xiong Z, Li Y, Zhang Y, Ma Z, Qi M, Zhang H, et al. RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury. Circulation. 2026. doi:10.1161/circulationaha.125.075591
BibTeX
@article{Xiong2026,
author = {Xiong, Zhenyu and Li, Yueyang and Zhang, Yan and Ma, Zhengjun and Qi, Meiying and Zhang, Huanle and Zhang, Xiaohua and Jiang, Mengyuan and Liu, Jie and Gao, Erhe and Li, Congye and Man, Wanrong and Zhang, Mingming and Hu, Jianqiang and Lin, Jie and Yang, Zhi and Fan, Li and Chen, Yundai and Sun, Dongdong},
title = {RND3 Enhances Cardiac Glucose Metabolism Through Inhibiting ACAT1-Dependent PDHA1 Acetylation and Protects Against Ischemia-Reperfusion Injury},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.125.075591}
}
EUVIMED